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The decision-making processes of a hospital pharmacy adminis-
trator include the determination of the most advantageous means by 
which intravenously administered drugs may be prepared and distri-
buted. Systems to accomplish this have become increasingly more 
efficient, less hazardous to the patient, but more costly to the 
1-4 
Department of Pharmacy Services. These increases in costs have 
been passed on to the patient, and subsequently to third party payers 
of health care services. One such system is the piggyback bottle 
system, which is currently in use at University Hospital. 
The introduction of the prospective payment system by several 
third party payers of health care services will require hospital 
pharmacy administrators to evaluate and justify the cost of preparing 
and distributing intravenously administered drugs. A system which 
purportedly has the same advantages as those of the piggyback bottle 
system, but at a reduced cost to the Department of Pharmacy Services, 
is the Harvard® Mini-Infuser System. A comparative study of the two 
systems was performed to determine actual cost savings at University 
Hospital. 
OBJECTIVE 
The objective of this study was to determine the comparative 
personnel and material acquisition costs to the Department of Pharmacy 
Services at University Hospital of two systems for the intermittent 
intravenous administration of drugs. 
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DESCRIPTION OF THE SYSTEMS 
The two systems involved were the piggyback bottle system and the 
proposed syringe infusion system, the Harvard® Mini-Infuser System. 
The piggyback bottle system is illustrated in Figure 1. A 
primary intravenous solution container delivers solution to the 
patient via a primary infusion set and extension set. The primary 
infusion set contains a one-way valve, roller clamp, and a Y-injection 
site. A secondary piggyback set, with a roller clamp, is connected to 
this Y-injection site. The piggyback bottle containing the drug for 
intravenous infusion is attached to the secondary piggyback set by 
inserting the spiked end of the secondary piggyback set into the 
piggyback bottle. The intravenous drug solution is gravity-delivered, 
with the rate of delivery determined by the roller clamp on the 
secondary piggyback set or by the roller clamp on the primary infusion 
set. 
Variations of this system may be used at other hospitals. A 
minibag may be substituted for the piggyback bottle. Also, a primary 
infusion solution may not be used, and the piggyback bottle, or 
minibag, may be infused directly into a peripheral vein via an intermit-
tent infusion set (heparin lock). 
The syringe infusion system is illustrated in Figure 2. This 
system consists of a syringe, an administration set, and an infusion 
pump. The syringe is a plastic, calibrated, disposable syringe that 
may vary in size from 3 to 60 milliliters. The variation in size 
depends on the stability and dilutional requirements of the drug to be 
administered. 
A primary intravenous solution container delivers solution to the 
patient via a primary infusion set and extension set. The primary 
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infusion set incorporates neither a one-way valve nor a Y-injection 
site. However, to the Y-injection site on the extension set is con-
nected the administration, or secondary microbore set. This secondary 
microbore set is a disposable, microbore tubing (manufactured by C.R. 
Bard, Inc.) that resists kinking, requires minimal fluid for priming, 
and attaches to the syringe via a winged luer lock fitting. A varia-
tion of this part of the system may be used at other hospitals. The 
primary infusion container, primary infusion set and extension set may 
not be used. Instead, the secondary microbore set, with a needle 
attached, may be connected directly to an intermittent infusion set 
(heparin lock). 
The drug-containing syringe, with the attached secondary micro-
bore set, is placed in the syringe holder of the infusion pump. The 
infusion pump is a battery operated, single speed syringe infusion 
pump. It is designed for accurate, controlled, infusion of drugs that 
are to be administered by intermittent intravenous infusion in 40 
minutes or less. The pump has audible and visual alarms to indicate 
the end of an infusion in progress, or low battery power. The pump 
will alarm and automatically shut off at the end of an infusion or an 
occlusion (four to eight pounds per square inch occlusion force, 
depending on model of pump).^ 
METHODS 
This investigation was conducted as a prospective, comparative 
study of the current piggyback bottle system in use at University 
Hospital and the Harvard® Mini-Infuser System. The piggyback bottle 
system provided the baseline data, and the Harvard system the 
4 
comparative study data. Personnel and material acquisition costs were 
determined for each system. 
Personnel Costs 
Baseline data collection consisted of identifying, as measurable 
units, the activities involved in the preparation of drug doses into 
piggyback bottles by the pharmacists of the centralized Intravenous 
Admixture Service (Appendix). Once identified, these activities were 
observed, timed, and recorded for a 14-day period, using the continu-
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ous stopwatch technique as described by Miller et al, for all orders 
of small volume parenterals. The total number of doses prepared was 
recorded. 
A general surgical unit consisting of 32 beds was selected as the 
study unit. Characteristics of the unit which made it desirable for 
study included its size, the number of small volume parenterals 
ordered and the enthusiasm and cooperation of the nursing personnel. 
A four week education and orientation period followed baseline data 
collection. During this time period, pharmacy and nursing personnel 
servicing this patient care unit familiarized themselves with the 
procedures involved in utilizing the Harvard® system. 
At the end of the four week period, pharmacists of the centra-
lized Intravenous Admixture Service had achieved a consistent level of 
efficiency and study data were collected for the Harvard® system. The 
activities involved in the preparation of drug doses for the Harvard® 
system by the pharmacists of the centralized Intravenous Admixture 
Service were identified as measurable units in the same manner as was 
done for the piggyback bottle system (Appendix) . The data were col-
lected for a 14-day period in the same manner as was done for the 
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piggyback bottle system for all orders of small volume parenterals. 
The total number of doses prepared was recorded. 
When compared, the only activities performed differently for the 
two systems were stocking and retrieval, transferring, and labeling of 
the drugs (Appendix). These steps were then used to determine the 
difference in preparation time between the two systems by comparing 
those drugs prepared in both systems. The average salary of the 
pharmacists of the centralized Intravenous Admixture Service was then 
applied to the preparation times to determine the difference in 
personnel costs of the two systems. 
Material Acquisition Costs 
The materials used in the preparation of small volume parenterals 
for the piggyback bottle system and the Harvard® system were observed, 
recorded, and itemized according to fixed and variable costs. Fixed 
costs related to those items for which the cost per dose would not 
vary with the number of doses prepared. Variable costs related to 
those items for which the cost per dose would vary according to how 
many doses were used per item. The actual hospital acquisition costs 
of the materials used at University Hospital were then determined. 
The cost of transfer needles was determined as an average cost per 
dose. This cost was determined in this manner as not all doses 
utilized a transfer needle, but this cost was unique to the piggyback 
bottle system and was included as a fixed cost for that system. 
Minimal costs common to both systems (alcohol swabs, etc.) were not 
considered for the purpose of this comparative analysis. 
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The annualized purchases for calendar 1983 were determined for 
piggyback bottles, primary infusion sets (adult and pediatric) and 
secondary piggyback sets. From these data the following were deter-
mined: 1) the percent of adult primary infusion sets used; 2) the 
number of piggyback bottles used for adult doses; 3) the number of 
secondary piggyback sets used for adult doses; 4) the number of 
primary infusion sets used per adult dose; and 5) the number of 
secondary piggyback sets used per adult dose. Only adult piggyback 
bottle doses were considered for conversion to the Harvard® system. 
A basic assumption of hospital pharmacy management at University 
Hospital was that approximately 80 percent of adult piggyback bottle 
doses could be converted to the Harvard® system. This percentage was 
based on the number of drugs for which the dilutional and administra-
tion requirements allowed the intermittent intravenous infusion of the 
small volumes necessary to utilize the Harvard® system. This assump-
tion, along with the data derived from the annualized purchases for 
calendar 1983 and the fixed and variable costs, were used to calculate 
the total costs for the implementation year and second year for both 
systems. Costs were calculated for the varying number of doses (from 
1 to 8) that could be given per Harvard® secondary microbore sets. 
These data were compared to current cost data of the piggyback bottle 
system for the same time period and provided information to determine 
the dose-to-secondary microbore set ratio which would make the Harvard® 
system cost-effective. This dose-to-secondary microbore set ratio was 
used in the final cost analysis of the two systems. No future provider 
price increases were taken into account for either system. 
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Syringe infusion pumps for the Harvard® system could be purchased 
by contract agreement, either in conjunction with, or separately from, 
a specified number of case purchases of secondary microbore sets. 
With the former option, the cost of the secondary microbore sets would 
reflect the purchase of the syringe infusion pumps and would cost more 
than if no syringe infusion pumps were included with case purchases. 
Hospital pharmacy management decided that the number of syringe 
infusion pumps needed at University Hospital could best be purchased 
utilizing the option of purchasing a specified number of cases of 
secondary microbore sets, at the higher cost, for the first year of 
use of the Harvard® system. 
RESULTS 
Personnel Costs 
The time involved for the activities of stocking and retrieval, 
transferring, and the labeling of drugs were determined for the 
following drugs which were prepared in both systems: cefazolin 
sodium, cefoxitin sodium, cephapirin sodium, cimetidine, clindamycin 
phosphate, gentamicin sulfate, nafcillin sodium, and penicillin G 
potassium. All dosages ordered for each drug were included. The mean 
(± standard deviation) time per dose for all activities listed in the 
Appendix was 15.7 ± 27.4 seconds for the piggyback bottle system and 
17.5 ± 20.6 seconds for the Harvard® system. The mean (± standard 
deviation) time involved for those activities that were performed 
differently between the two systems are presented in Table 1. Each 
activity took more time to perform in the Harvard® system. Transfer-
ring of the drug to the final container (syringe) took the most time. 
8 
However, the difference in the time required for preparation was 
approximately two seconds. When the average salary for the centra-
lized Intravenous Admixture Service pharmacists was applied to this 
difference, only minimal cost difference for personnel could be 
demonstrated between the two systems (approximately $0,012 per dose, 
or $811.10 per 67,592 doses). 
Material Acquisition Costs 
Fixed and variable costs, as previously defined, for each system 
are presented in Table 2. The fixed costs per dose were less for the 
Harvard® system ($0,196) compared to the piggyback bottle system 
($0,850). The variable costs per dose were less for the piggyback 
bottle system ($2,516) compared to the Harvard® system ($4,093), 
during the implementation year. However, the variable costs per dose 
were similar for the two systems during the second year ($2,516 
compared to $2,520). 
The annualized purchases for calendar 1983 and the usage analysis 
from these purchases were determined. One adult primary infusion set 
was used for at least four piggyback bottle doses. One secondary 
piggyback set was used for each adult piggyback bottle dose. Eighty 
percent conversion of adult piggyback bottle doses to syringe doses 
would result in 67,592 syringe doses for use with the Harvard® system. 
The dose-to-secondary microbore set ratio for the Harvard® system was 
calculated for one to eight doses per secondary microbore set. The 
dose-to-secondary microbore set ratio for cost-effectiveness was 
4-to-l to 5-to-l. These ratios, along with the current dose-to-
secondarv piggyback set ratio of 1-to-l are presented in Table 3. If 
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the ratio was held constant at the current 1-to-l ratio of the piggy-
back bottle system, the Harvard® system would cost $114,694 more to 
maintain in the implementation year. Therefore, as the dose-to-
secondary microbore set ratio increases, the Harvard® system becomes 
more cost-effective. 
Table 4 presents the final cost analysis of the two systems based 
on the minimum cost-effective dose-to-secondary microbore set ratio of 
4-to-l. The number of secondary microbore sets purchased was greater 
than the number calculated for use by approximately 1,100 sets. These 
additional sets were purchases in accordance with a contract agreement 
for the purchase of full case lots of secondary microbore sets to pay 
for an initial 110 syringe infusion pumps that were anticipated to be 
utilized. An additional 10 syringe infusion pumps were projected for 
purchase over the initial 110 syringe infusion pumps. The Harvard® 
system would have proposed cost savings of $40,674 for the implementa-
tion year, and $71,454 for the second year. The projections for the 
second year were based on the same data used for the implementation 
year and did not assume any changes in usage or provider cost that 
could occur during these time periods. 
DISCUSSION 
The Harvard® Mini-Infuser System is a system for the intermittent 
intravenous administration of drugs that maintains acceptable standards 
for safety and drug delivery, and can provide a cost savings to the 
hospital and the Department of Pharmacy Services. Measurable areas of 
cost savings are personnel and material acquisition costs. 
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When comparing the personnel costs of the two systems, essentially 
no difference was found. However, variations were noted between the 
two systems. The Harvard® system required more time to transfer the 
drug to the syringe, and more time was needed to place the label on 
the syringe. These differences were probably related to an increase 
in manipulation of the syringe due to its size, as compared to a 
piggyback bottle. Also, stocking and retrieval of the syringe took 
more time to perform. This was probably related to the size and 
packaging of the syringe, which required the pharmacist to more 
accurately count and separate the number of syringes used. 
Cost savings were demonstrated for material acquisition costs. 
These costs were itemized into fixed and variable costs. The differ-
ence in fixed costs was related to the use of the less expensive 
syringe. If the more expensive minibag is used in place of a piggyback 
bottle, this difference in fixed costs would be even larger. The 
difference in fixed costs was offset by the more expensive secondary 
microbore sets of the Harvard® system. At University Hospital, both 
systems employed the use of a primary intravenous solution with a 
primary infusion set and extension set. The primary intravenous 
solution and extension set were considered the same in both systems 
and were not included in the cost analysis. However, to reduce the 
higher variable costs of the Harvard® system, a less expensive 
primary infusion set was used in the Harvard® system. The higher 
expense was particularly evident if the dose-to-secondary microbore 
set ratio is maintained at 1-to-l, as it is for the current piggyback 
bottle system. Therefore, to realize a cost savings for the Harvard® 
system the number of doses administered per secondary microbore set 
must increase to a ratio of at least 4-to-l for the first year of use. 
Assuming four doses administered per 24 hour period, each secondary 
microbore set would need to be used for at least 24 hours. This 
length of use for a secondary intravenous set is within the guidelines 
established by the National Intravenous Therapy Association^ for the 
intravenous administration of drugs. This change in usage pattern for 
the secondary microbore set, compared to the secondary piggyback set, 
would require both nursing personnel cooperation and education. 
Cost savings were increased from the implementation year to the 
second year. This increase was related to the difference in cost of 
the secondary microbore sets of the Harvard® system. In the implementa-
tion year secondary microbore sets were purchased, under contract 
agreement, at the higher cost to allow the purchase of an initial 110 
syringe infusion pumps. The following year, no syringe infusion pumps 
were projected to be purchased in this manner, and the cost of the 
secondary microbore sets was reduced. Future secondary microbore set 
purchase costs would then be based on the volume of sets purchased. 
An additional cost savings between the two years was based on the 
option to purchase an additional 10 syringe infusion pumps during the 
implementation year and not to purchase any syringe infusion pumps 
during year two. If more than 10 syringe infusion pumps were purchased 
during the implementation year the cost savings between the two years 
would be larger, but the total cost savings for the two years would be 
less. Cost savings in the second year would be less if any additional 
syringe infusion pumps were purchased during that year, and the total 
cost savings would be decreased, accordingly. The savings projected 
® 
for the Harvard system could be minimized by price increases for the 
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piggyback bottles and intravenous solutions if the provider determined 
that the usage of these products was now below prior contract agreement 
and increased the prices. 
Inventory costs were not calculated for either system. However, 
changes in inventory were projected to result from the use of the 
Harvard system. The frequency of ordering materials would not be 
expected to change, however, the number and type of items purchased 
would change. Storage space in the pharmacy stockroom would be 
gained, as less area would be needed to store an equal number of 
syringes, as compared to piggyback bottles. Additional pharmacy 
storage space gains would be possible at University Hospital as the 
pharmacy could order syringes from central supply as needed, thus 
decreasing the need to keep a large supply of syringes in the pharmacy 
stockroom. The secondary microbore set inventory purchased in excess 
of projections would require extra space for storage. However, this 
inventory would be distributed among pharmacy and the various patient 
care units at University Hospital and space requirements would be 
minimal. 
Personnel attitudes are important factors in the complete evalua-
tion of the Harvard® system, but were not formally investigated in 
this study. Subjective assessment of pharmacy and nursing personnel 
attitudes were very encouraging, since both found the Harvard® system 
to require minimal attention and effort to use. Problems, such as the 
initial determination of appropriate syringe size and type, and the 
need to determine whether or not the syringe was to be placed in the 
patient's unit dose medication cassette, did not deter this enthusiasm 
for the Harvard® system. 
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CONCLUSION 
The Harvard® Mini-Infuser System is a system for the intermittent 
intravenous administration of drugs that meets acceptable standards 
for safety and drug delivery. The advantage of this system was a 
reduction in cost to the Department of Pharmacy Services at University 
Hospital. This cost reduction was related to the reduction in material 
acquisition costs, provided the appropriate number of doses of drug 
given per secondary microbore set could be determined and maintained. 
Personnel acceptance and a tentative reduction in nursing time con-
current with increased ease of use, although not measured in this 
study, would make the cost savings more acceptable to a hospital 
pharmacy administrator and hospital administration. 
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Figure 2. Harvard® Mini-Infuser System. 
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Table 1. The mean (+ standard deviation) time for activities that 
were performed differently for the piggyback bottle system 





Seconds, per prepared dose 
Piggyback 
Bottle System 
2.7 + 2.0 
10.9 + 6.6 
1.0 + 1.4 
Harvard Mini-
Infuser System 
3.4 + 2.8 
12.0 +4.0 
1.9 + 1.4 
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Table 2. Fixed and variable costs per dose for the piggyback bottle 






Small volume container $0,760 $0,140* 
Label 0.020 0.006 
Container safety seal 0.050 0.050 
Transfer needle 0.020 -0-
Total $0,850 $0,196 
Variable Costs 
Secondary set $0,820 $3.3732 
Primary infusion set, 
with valve, adult 1.696 -0-
Primary infusion set, 
plain, adult -0- 0.720 
Total $2,516 $4,093 
Average cost of various syringe sizes. 
2 This cost is $1.80 for second year of use. 
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Table 3. Cost effectiveness projections based on the ratio of the 








D :MS = 1:1 (MS = 67,592)2 
Primary infusion set, 
adult $ 24,706 $ 10,488 $ 14,218 
Fixed costs 57,453 13,248 44,205 
Variable costs 45,431 227,988 (182,557) 
Total $127,590 $242,284 $(114,694) 
D:MS = 4:1 (MS = 16,898)2 
Primary infusion set, 
adult $ 24,706 $ 10,488 $ 14,218 
Fixed costs 57,453 13,248 44,205 
Variable costs 45,431 56,997 (11,566) 
Total $127,590 $ 80,733 $ 46,857 
D :MS = 5:1 (MS = 13,518)2 
Primary infusion set, 
adult $ 24,706 $ 10,488 $ 14,218 
Fixed costs 57,453 13,248 44,205 
Variable costs 45,431 45,596 (165) 
Total $127,590 $ 69,332 $ 58,258 
^Piggyback bottle system minus Harvard® Mini-Infuser System. 
2 
Denotes number of secondary microbore sets to calculate variable costs. 
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Table 4. Final cost analysis of the piggyback bottle system and the 
Harvard® Mini-Infuser System. 
Piggyback Bottle System 








Primary infusion sets, 
adult 
Secondary microbore sets 
Fixed costs 














$ 24,706 $ 24,706 $ 50,864 
90,862 
114,906 
$127,590 $127,590 $255,180 




$ 86,916 $ 56,136 $143,052 
Proposed savings 
Microbore set inventory 
above projection, dollars 
Microbore set inventory 
above projection, number 
Microbore set inventory 
period above projection 
$ 40,674 $ 71,454 $112,128 




3 weeks 6 weeks 
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Activities identified during the preparation of intermittent intravenous 
drug doses. 
1. Type labels 
2. Batch separation of labels 
3. Stocking/retrieval of materials* 
a. Syringes 
b. Piggyback bottles 
c. Diluent 
d. Drug already reconstituted 
e. Drug not reconstituted 
4. Reconstitute drug 
5. Transfer of reconstituted drug to small volume parenteral* 
a. Via multiple-dose syringe system 
b. Via transfer needle 
c. Via transfer pin and syringe/needle 
d. Via single syringe 
6. Snap open ampules 
7. Cleaning small volume parenteral with alcohol; remove seals 
8. Sealing with volume parenteral 
9. Label placement* 
10. Initialing of label 11. Transfer small volume parenteral to cart 
12. Adjustment of small volume parenteral for volume/pressure 
13. Return materials to storage after use 
Activities that were performed differently for the two systems 
McAllister JC, Buchanan EC, Skolaut MW. A comparison of the 
safety and efficiency of three intermittent intravenous therapy 
systems - the minibottle, the minibag, and the inline burette. 
Am J Hosp Pharm. 1979; 31:961-67. 
Miller WA, Smith GL, Latiolais CJ. A comparative evaluation of 
compounding costs and contamination rates of intravenous admixture 
systems. Drug Intell Clin Pharm. 1971; 5:51-60. 
Paxinos J, Hammel RJ, Fritz WL. Contamination rates and costs 
associated with the use of four intermittent intravenous infusion 
systems. Am J Hosp Pharm. 1979; 36:1497-1503. 
Stipe AA. Syringe infusion pumps: A delivery system for intermit-
tent intravenous drug delivery. Infusion. 1980; 4:99-101. 
Bard MedSystems Division, C.R. Bard, Inc., Harvard Mini-Infuser 
System product information. North Reading, MA. 1983. 
Anon. Standards: Recommendations of Practice of the National 
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